[Proneuron1] Periodic newsletter

[proneuron1 at list.proneuron.com]

Greetings,

This is the first of a series of periodic newsletters that will be e-mailed
to those on the Proneuron subscribers list.
Until now, we have been in touch to share milestones and important news.
Recognizing that certain items are of more interest to some rather than
others, we have decided to reorganize our information output system. In the
future, rather than individual press releases and bulletins, Proneuron
subscribers will hereon in receive a periodic tailored newsletter,
highlighting the company's progress, advancements and relevant plans of the
coming months. 
The last quarter or so was particularly exciting. Highlights of this quarter
are::
*	Proneuron Receives Eagle Star Award
(http://www.proneuron.com/News/NewsFiles/News_36.html) 
*	Proneuron Signs Agreement with Cell Dynamics of Atlanta
(http://www.proneuron.com/News/NewsFiles/News_38.html) 
*	Phase II study of ProCord now open for Enrollment at the Kessler
Institute for Rehabilitation and the Mount Sinai Medical Center
(http://www.proneuron.com/News/NewsFiles/News_37.html)

The next few months also promise to be busy. Proneuron has been invited to
present abstracts at a series of prestigious conferences and events. For a
full listing, please visit:
(http://www.proneuron.com/news/Upcoming_Events.html).
Finally, Proneuron was featured in articles in the following publications:
*	New Mobility, June 2004 issue 
*	The New Scientist, June 12, 2004 issue 
*	Detroit Free Press, April 13, 2004 issue 
*	Naamat, Spring issue 
*	BusinessWeek, March 16, 2004 (on line) 
*	TV reports: NPR and local Atlanta stations

In addition, the Proneuron website was recently modified to make it faster
and easier to navigate. We have also introduced some new features. These
include:
"Upcoming Events" (http://www.proneuron.com/news/Upcoming_Events.html) is a
new section listing the conferences and events where Proneuron will be
represented. In some instances, presentation abstracts are provided.
For the students and scientists amongst our you: the entries in the
scientific bibliography list
(http://www.proneuron.com/Technology/Publications.html) are now individually
linked to their abstracts in "PubMed" (the complimentary on-line
bibliographic database run by the U.S. National Library of Medicine).
Should you wish to contact Proneuron, please use one of the addresses noted
below. Additional contact info can be found on our website:
www.proneuron.com.

clinical.trial at proneuron.com (recruitment of recent spinal cord injury
patients for the ProCord clinical trial)
webmaster at proneuron.com (website errors, problems or suggestions for site
improvement)
careers at proneuron.com (job applications)
information at proneuron.com (general inquiries)
marjie.hadad at proneuron.com (press inquiries) 

Thank you in advance for your continued interest and support.

Best wishes,
Nir
--------------------------------------------------
Nir Nimrodi, CEO
Proneuron Biotechnologies, Inc.
US office: 1801 Century Park East, Los Angeles, CA 90067
Israel office: P.O.B 277, Ness Ziona, 74101
Tel. +972-8-9409550,   Fax. +972-8-9409560
Mobile  +972-544-618131
Web site: www.proneuron.com

Who to call for the ProCord SCI clinical trial?
24 hour a day Patient Recruitment Center: 
Email: clinical.trial at proneuron.com 
Telephone: +1 866 539 0767 (U.S. toll free) or +1 506 652 3486. 
*Callers outside of the U.S., please use standard international dialing code